In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer

Non-Hispanic Black patients with breast cancer undergoing neoadjuvant chemotherapy have a lower likelihood of experiencing pathologic complete response compared with non-Hispanic White patients. A new study examines several potential reasons why.

Early Diagnosis and Treatment of Cancer by juan jaramillo - Issuu

Pathologic complete response and overall survival in breast cancer

Pre-surgical Immunotherapy Benefits Are Independent of Race in

Racial disparities in breast cancer may have genetic factor - STAT

African-American Breast Cancer Patients Can Improve Their Outcomes

Outcomes in breast cancer—does ethnicity matter? - ScienceDirect

Disparities in Clinical Research and Cancer Treatment

Flowchart of the study population. NACT: neoadjuvant chemotherapy

Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during

MammaPrint® Index as a predictive biomarker for neoadjuvant

Cureus Mammographic and Ultrasonographic Imaging Analysis for

Triple negative breast cancer: Pitfalls and progress

In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer

Reducing Racial Disparities in Early Cancer Diagnosis With Blood